CORE

🇺🇦   make metadata, not war

    4 research outputs found

    805 Oncolytic adenovirus encoding human interleukin-7 in combination with ICIs as a treatment strategy against renal cell carcinoma (RCC)

    Author
    Publication venue
    BMJ Publishing Group
    Publication date
    Field of study
    No full text
    Directory of Open Access Journals

    711 Development of oncolytic adenovirus Ad5/3-E2F-D24-hTNFa-IRES-hIL2 (TILT-123) for the treatment of solid tumours – from preclinical testing to phase I clinical trials

    Author
    Publication venue
    BMJ Publishing Group
    Publication date
    Field of study
    No full text
    Directory of Open Access Journals

    739 Emerging proteomic and safety analysis of blood from solid tumor patients receiving TILT-123 (Ad5/3-E2F-d24-hTNFa-IRES-hIL2) monotherapy in TUNIMO phase 1 clinical trial

    Author
    Publication venue
    BMJ Publishing Group
    Publication date
    Field of study
    No full text
    Directory of Open Access Journals

    1518 T-cell inducing oncolytic virus (igrelimogene litadenorepvec; TILT-123) shows safety, anti-tumor activity and induction of immune responses in advanced solid tumor patients (full report on TUNIMO)

    Author
    Publication venue
    BMJ Publishing Group
    Publication date
    Field of study
    No full text
    Directory of Open Access Journals
    corecore